Last edition
News about "Teva Pharmaceuticals"
ScinoPharm Wins FDA Approval for Glatiramer Acetate Injection
ScinoPharm Taiwan has received US FDA approval for its Glatiramer Acetate Injection for the treatment of multiple sclerosis, marking a significant milestone as the first and only Taiwanese pharmaceutical company to secure FDA approval for this complex generic, and reinforcing Taiwan’s growing role in the global pharmaceutical supply chain.
Teva Pharmaceuticals | 05/01/2026 | By News Bureau
CCT, Kuehne+Nagel and Teva Prove Ocean Freight Viable for Temperature-Sensitive Pharmaceuticals
Cold Chain Technologies (CCT), a global leader in temperature-controlled packaging, has successfully completed a landmark project with logistics giant Kuehne + Nagel and Teva Pharmaceuticals, demonstrating the viability of ocean freight for high-value, temperature-sensitive pharmaceutical shipments.
Teva Pharmaceuticals | 15/10/2025 | By Dineshwori | 348
Teva Pharmaceuticals Launches First Generic Version of Saxenda in US
The first generic version of Saxenda, Liraglutide injection, is approved for adults with obesity or overweight who have weight-related medical conditions, as well as for paediatric patients aged 12 to 17 years weighing more than 60 kg with obesity.
Teva Pharmaceuticals | 30/08/2025 | By Dineshwori | 659
Global Topical Antibiotics Market Projected to Surpass USD 11 Billion by 2032
The global topical antibiotics market, valued at USD 6.42 billion in 2024, is expected to reach nearly USD 11.20 billion by 2032.
Teva Pharmaceuticals | 14/07/2025 | By Dineshwori | 208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy